drugset / Trial / NCT00383864
Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to evaluate the efficacy (and safety) of antiviral therapy in patients with chronic hepatitis C after liver transplantation. The only approved drugs for treatment of hepatitis C are pegylated interferon and ribavirin.
Timeline
- Start
- 2001-07
- Primary completion
- —
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Peginterferon alfa-2b | Protein / enzyme biologic | — | — |
| Subject | Ribavirin | Small molecule | — | — |